Vascular Medicine

Feature Article

Systemic Vascular Health Associated With Widespread Brain Changes

Systemic Vascular Health Associated With Widespread Brain Changes

Systemic vascular health measured as a composite of recent cardiovascular and metabolic chronic conditions was associated with medial temporal lobe thinning, widespread cerebral hypoperfusion, and poor microstructural integrity.

Latest Features

ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention

ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention

In publishing updated appropriate use criteria, the organizations hope to provide guidance to clinicians who may refer patients for revascularization therapy.

Questions Remain Regarding VTE Recurrence in Older Adults

Questions Remain Regarding VTE Recurrence in Older Adults

Venous thromboembolism recurrence risk may not be any higher in older patients than in younger patients.

The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

Recent evidence links specific bacterial, viral infections, and vaccination to the development of APS, but these associations are not clear-cut.

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

South Asians exhibit the highest rates of ASCVD among all ethnic groups, and the highest prevalence is in younger age groups; up to 25% of myocardial infarctions in India occur in individuals younger than 40 years of age.

Rheumatic Heart Disease: Diagnosis and Management

Rheumatic Heart Disease: Diagnosis and Management

Learn about the comprehensive management of rheumatic heart disease with Jack Boyd, MD, clinical assistant professor of cardiothoracic surgery at Stanford University School of Medicine.

Latest News

Systemic Vascular Health Associated With Widespread Brain Changes

Systemic Vascular Health Associated With Widespread Brain Changes

Systemic vascular health measured as a composite of recent cardiovascular and metabolic chronic conditions was associated with medial temporal lobe thinning, widespread cerebral hypoperfusion, and poor microstructural integrity.

Rivaroxaban Supplemental New Drug Application Submitted to FDA for VTE Prophylaxis

Rivaroxaban Supplemental New Drug Application Submitted to FDA for VTE Prophylaxis

The sNDA submission was supported by Phase 3 data from the MAGELLAN and MARINER trials which assessed the use of rivaroxaban in preventing VTE in acute medically ill patients while hospitalized and immediately after discharge.

Clinical Practice Guidelines for VTE Management Updated

Clinical Practice Guidelines for VTE Management Updated

The guidelines were developed by over 100 experts, including hematologists, patient representatives, and other specialists.

CMR May Detect Cardiac Complications in Lupus

CMR May Detect Cardiac Complications in Lupus

Researchers sought to determine whether a cardiovascular magnetic resonance protocol may be useful for early diagnosis of heart disease in patients with systemic lupus erythematosus.

Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes

Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes

Metformin improved insulin resistance regardless of baseline BMI in adolescents with type 1 diabetes.

Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials

Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials

Second- and third-generation tyrosine kinase inhibitors are associated with a variety of cardiovascular events.

Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks

Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks

The US Food and Drug Administration has identified this as a Class I recall, with continued device use resulting in serious injury or death.

Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD

Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD

The FDA has approved Xarelto (rivaroxaban) to reduce the risk of MACE, such as CV death, myocardial infarction and stroke, in patients with chronic coronary or peripheral artery disease.

Femoral Artery Atherosclerosis More Common in Psoriasis

Femoral Artery Atherosclerosis More Common in Psoriasis

The results indicated that participants with psoriasis had a significantly higher prevalence of femoral plaques compared with control patients.

Anti-Nicotine Monoclonal Antibody Gets Orphan Drug Status for Buerger's Disease

Anti-Nicotine Monoclonal Antibody Gets Orphan Drug Status for Buerger's Disease

Buerger's disease is a nonatherosclerotic, segmental inflammatory disorder that affects small and medium vessels of the upper and lower extremities and is strongly associated with tobacco exposure.

Sign Up for Free e-Newsletters